Aurora-A/NF-ĸB Signaling Is Associated With Radio-resistance in Human Lung Adenocarcinoma

Area of Science:

• Oncology
• Molecular Biology
• Radiotherapy Research

Background:

• Lung adenocarcinoma is a significant cause of cancer mortality.
• Docetaxel resistance and radioresistance are major challenges in treating lung adenocarcinoma.
• Understanding molecular mechanisms underlying treatment resistance is crucial for improving patient outcomes.

Purpose of the Study:

• To investigate the role of Aurora-A/NF-ĸB signaling in the radioresistance of human docetaxel-resistant lung adenocarcinoma cells.
• To elucidate the molecular mechanisms by which Aurora-A influences radiotherapy resistance.
• To identify potential therapeutic targets for overcoming treatment resistance.

Main Methods:

• Utilized human lung adenocarcinoma cell lines (SPC-A1 and SPC-A1/DTX).
• Assessed radiosensitivity using MTT assays and quantified apoptosis via flow cytometry.
• Measured mRNA and protein expression of Aurora-A and NF-ĸB using real-time quantitative PCR and western blotting.
• Evaluated in vivo tumor radiosensitivity in nude mouse models.

Main Results:

• Docetaxel-resistant SPC-A1/DTX cells exhibited significantly higher radioresistance compared to parental SPC-A1 cells.
• Upregulated Aurora-A was identified as a key factor in the in vitro radioresistance of SPC-A1/DTX cells.
• Nuclear transcription factor NF-ĸB was confirmed as a downstream target of Aurora-A, playing a role in the radioresistance mediated by Aurora-A.

Conclusions:

• The Aurora-A/NF-ĸB signaling pathway is closely associated with the radioresistance observed in human docetaxel-resistant lung adenocarcinoma cells.
• Targeting the Aurora-A/NF-ĸB pathway may offer a novel strategy to enhance radiotherapy efficacy in resistant lung adenocarcinoma.
• Further research into this pathway could lead to the development of more effective treatment regimens for resistant lung adenocarcinoma.